In vitro and in vivo antitumour effects of phenylboronic acid against mouse mammary adenocarcinoma 4T1 and squamous carcinoma SCCVII cells

Inhibition of Horseradish Peroxidase Activity by Boroxine Derivative, Dipotassium-trioxohydroxytetrafluorotriborate K2[B3O3F4OH]

(2017) Jelena Ostojic et al.   Journal of Chemistry

Phenylboronic Acid-Mediated Tumor Targeting of Chitosan Nanoparticles

(2016) Xin Wang et al.   Theranostics

Enhanced expression of polysialic acid correlates with malignant phenotype in breast cancer cell lines and clinical tissue samples

(2015) XIN WANG et al.   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE

Nanoscaled boron-containing delivery systems and therapeutic agents for cancer treatment

(2015) Jing Wang et al.   Nanomedicine

A study of the inhibition of catalase by dipotassium trioxohydroxytetrafluorotriborate K2[B3O3F4OH]

(2014) Safija Islamovic et al.   JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY

Dipotassium-trioxohydroxytetrafluorotriborate, K2[B3O3F4OH], is a potent inhibitor of human carbonic anhydrases

(2014) Daniela Vullo et al.   JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY

In vitroandin vivoantitumor activity of the halogenated boroxine dipotassium-trioxohydroxytetrafluorotriborate (K2[B3O3F4OH])

(2014) Sinisa Ivankovic et al.   JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY

Boron-containing acids: Preliminary evaluation of acute toxicity and access to the brain determined by Raman scattering spectroscopy

(2013) Marvin A. Soriano-Ursúa et al.   NEUROTOXICOLOGY

Aminoferrocene-Based Prodrugs Activated by Reactive Oxygen Species

(2011) Helen Hagen et al.   JOURNAL OF MEDICINAL CHEMISTRY

Hydrogen Peroxide Inducible DNA Cross-Linking Agents: Targeted Anticancer Prodrugs

(2011) Yunyan Kuang et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Phenylboronic acid is a more potent inhibitor than boric acid of key signaling networks involved in cancer cell migration

(2011) Erin M. McAuley et al.   Cell Adhesion & Migration

Guidelines for the welfare and use of animals in cancer research

(2010) P Workman et al.   BRITISH JOURNAL OF CANCER

Boronic acids in medicinal chemistry: anticancer, antibacterial and antiviral applications

(2010) Paul C. Trippier et al.   MedChemComm

Phenylboronic acid selectively inhibits human prostate and breast cancer cell migration and decreases viability

(2010) Tiffany M. Bradke et al.   Cell Adhesion & Migration

Therapeutic potential of boron-containing compounds

(2009) Stephen J Baker et al.   Future Medicinal Chemistry